Big Data in Pharma – Strategic Intelligence

Reasons to buy the ‘Big Data in Pharma’ strategic intelligence report:

• Understand the key trends accelerating or hindering big data in the pharma space.
• See market forecasts for different therapies within big data up to 2028.
• Understand recent and influential developments in big data.
• Review leaders and disruptors across the big data value chain.

How is our ‘Big Data in Pharma’ report unique from other reports in the market?

• A dedicated report examining the pivotal healthcare, technological, macroeconomic, and regulatory trends shaping the big data in the pharma landscape.
• This report also provides an in-depth analysis of how these trends are poised to either accelerate progress or create obstacles to the big data market growth.
• This report consolidates GlobalData’s latest thinking and forecasts around how the healthcare, macroeconomic, technology, and regulatory trends will impact big data in the pharma space, as well as providing insights into the leading players and future disruptors across the value chain, and providing insights into key drugs and markets.
• Additionally, this report is designed to provide strategic planners, competitive intelligence professionals, and key stakeholders in the pharmaceutical industry a clear view of the opportunities and risks over the foreseeable future for big data.

We recommend this valuable source of information to anyone involved in:

• Healthcare Practitioners (HCPs), Doctors/Physician, Healthcare Service Providers
• Healthcare Organizations (HTA Bodies, Reimbursement Groups and Payers, Government Healthcare Organizations)
• Big data Vendors – Startups & Leaders
• Consulting and Professional Services (e.g., Investment Companies, Investment Banks, Equity Companies, etc.)
• Pharma Manufacturers/Distributors (Innovative, Biotech, Generics, Biosimilars, Rare/Orphan Disease)
• Financial Institutions (Investors in Pharma/Biotech, Pricing Consultancies)

To Get a Snapshot of the Big Data in Pharma Report
Download a Free Sample Report

Big Data in Pharma Strategic Intelligence Report Overview

The international pharmaceutical landscape generates large amounts of data from sources such as patient registries, clinical trials, wearable technologies, and others. These datasets are vast, complex, and unstructured, rendering traditional big data analytical methodologies inefficient for processing. Owing to this, organizations within the pharmaceutical industry are innovating big data analytical technologies that can secure, store, process, analyze, aggregate, and integrate vast and complex datasets for the purpose of acquiring novel insights.

The ‘Big Data in Pharma’ strategic intelligence report gives an in-depth insight into the big data theme and how it will impact the market. It further entails a deep-dive analysis of the industry, including real-life use case studies and big data impact. The report also identifies the key market trends that will shape the big data theme over the coming years and gives an insight into the market players and the competitive landscape within the theme.

Big Data in Pharma – Key Trends

The key trends associated with the big data theme are healthcare trends, technology trends, macroeconomic trends, and regulatory trends.

• Healthcare trends: Virtual clinical trials, Precision and personalized medicine, integration of AI within big data, and others are a few of the healthcare trends impacting the healthcare trends.
• Technology Trends: The key technologies impacting the big data theme are big data and AI, cybersecurity, robotics, and others.
• Macroeconomic Trends: The impact of big data on drug pricing, accelerating information era, and increasing big data, AI, and ML collaborations are points to be considered for macroeconomic trends.
• Regulatory Trends: Data privacy, international regulatory differences, and regulatory collaborations are influencing the big data theme.

Buy the Full Report for More Trend Insights into the Big Data Theme
Download a Free Report Sample

Big Data Value Chain Analysis

The big data value chain is broadly categorized into big data generation, big data management, and big data product development.

Big Data Product Development: Datasets can be implemented with big data-driven products once they are efficiently and safely stored, secured, processed, and analyzed. Pharmaceutical organizations have the potential to optimize clinical trials, accelerate drug target discovery, drive innovation, and generate business insights by leveraging the extensive and wide variety of validated datasets available. They can also improve patient outcomes and personalized therapy solutions.

Big Data Value Chain Analysis

Buy the Full Report for More Insights into the Big Data Value Chain
Download a Free Report Sample

Big Data in Pharma - Leading Companies

A few of the leading big data vendors making their mark within the big data theme are:

• Alphabet
• Amazon
• Cisco Systems
• Complexica
• Dassault Systèmes

The following are the specialist big data vendors in pharma in the big data theme:

• Alteryx
• Antidote Technologies
• BenevolentAI
• BigOmics Analytics
• BioSymetrics

The leading big data adopters in pharma associated with the big data theme are:

• Amgen
• AstraZeneca
• Bayer
• Boehringer Ingelheim
• Eli Lilly and Co

Leading Players in the Big Data in Pharma Theme

Buy the Full Report to Know More About the Companies Making their Mark within the Big Data Theme or Download a Free Report Sample

Drug Manufacturing Sector Scorecard

At GlobalData, we use a scorecard approach to predict tomorrow’s leading companies within each sector. Our sector scorecard has three screens – a thematic screen, a valuation screen, and a risk screen.

• The thematic screen ranks companies based on overall leadership in the 10 themes that matter most to their industry, generating a leading indicator of future performance.
• The valuation screen ranks our universe of companies within a sector based on selected valuation metrics.
• The risk screen ranks companies within a particular sector based on overall investment risk.

Drug Manufacturing Sector Scorecard – Thematic Screen

Buy the Full Report for More Insights into the Sector Scorecard
Download a Free Report Sample